XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery
XtalPi unveiled its AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, announced in a press release. The event gathered scientists, biopharma innovators, and investors to discuss advances in targeting previously undruggable proteins.
XGlue integrates physics-based AI modeling with an autonomous synthesis workflow to form a closed-loop design–make–test system. This setup allows rapid iteration and expands the range of potential targets for molecular glue therapeutics.
Speakers from institutions including Stanford University, EPFL, and the Chinese Academy of Sciences presented research on computational design and rational discovery of molecular glues for diseases with unmet medical needs. Industry participants from companies such as Sanofi and Betta Pharma joined discussions on improving collaboration between academic research, industrial development, and clinical applications.
The symposium concluded with consensus on the importance of integrating AI, robotics, and cross-sector partnerships to advance protein degradation and accelerate the translation of molecular glue therapies into clinical use.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Sunthetics Joins $19.5M NSF Autonomous Lab Initiative
Tsingke Introduces Validation Workflow for AI Designed Proteins
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Tamar AI Launches Glanze Streaming Platform for AI Films
Lunai Bioworks Tests AI Chemical Risk Screening Model
Daily AI Brief: the AI news that matters, in your inbox.